With global regulatory changes happening quickly and often, there is concern that sponsors need more robust systems to keep pace and have a global disclosure strategy in place.
While several studies and surveys have examined the relationship between sponsors and CROs, there has been little analysis of CRO-investigative site relationships. This study uncovers useful learnings on the positive and negative experiences of investigators in their direct dealings with CROs.
By Applied Clinical Trials Editors
There are key cultural differences to be aware of before conducting clinical trials in Japan.
Japan is increasingly a region where opportunities for global registration studies abound, supported by government policies as well as the medical community and its local population. However, incorporating Japan as an integral part of your global trial execution strategy does not come without its unique challenges.
CRO giant and leading healthcare information provider merge to create a wide-ranging R&D-to-commercial services company, in a deal some contend could trigger a trend of larger CROs adding complementary non-clinical offerings.